chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After first dose had vertigo, that subsided after a white. After second dose had moderate vertigo and nausea which never completely faded but was on and off. After 3rd dose moderate vertigo, nausea,  that has not gone away. Several months after ringing in right ear, feeling of pressure -like. Hearing loss. Visited two ENTs. Last visit on 4-18-2023
Extreme chills and shaking of hands about 9pm. High fever all night-did not take Tylenol Temperature 102 in morning-Took 1 tablet of Tylenol Very weak.  Chills and fever.  Fainted about 9am. Chills throughout the day
ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT, UNSPECIFIED VEIN
24 hours after the injection, my left arm at the site of the injection swelled up and had a very large red rash around it the size of a baseball. This bump/swelling and rash lasted about 14 days before it went away. Pain overall was mild otherwise no other effects.
Information was received on 26-JUN-2017 from a nurse who reported that multiple unspecified patients received improperly stored PROQUAD (lot# M037651, expiration 28-FEB-2018) or VARIVAX (lot# M041081, expiration 06-OCT-2018) on unspecified dates. Temperature was 15F to 46 F (18.9F) for a time frame of one hour and 35 minutes. Previous temperature excursion was 15F to 46 F (22.9F) for four hours and 10 minutes. Call was because of a data logger. The diluent used to reconstitute the PROQUAD and VARIVAX was properly stored. No adverse effects reported. No further information was provided. Nurse agreed to follow-up. Additional information has been requested.
Shortness of breath; Middle of back and buttocks are still sore; Piercing ear pain; Cramps; Sweating profusely; Couldn't get out of bed; Tightness in the chest; Similar feeling to lingering symptoms after the flu; Body ache; A little tired; Headache; Chills; Major fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps) and HYPERHIDROSIS (Sweating profusely) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Major fever). On 26-Apr-2021, CHILLS (Chills) and PYREXIA (Major fever) had resolved. At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Middle of back and buttocks are still sore), EAR PAIN (Piercing ear pain), MUSCLE SPASMS (Cramps), HYPERHIDROSIS (Sweating profusely), ASTHENIA (Couldn't get out of bed), CHEST DISCOMFORT (Tightness in the chest), INFLUENZA LIKE ILLNESS (Similar feeling to lingering symptoms after the flu), MYALGIA (Body ache), FATIGUE (A little tired) and HEADACHE (Headache) outcome was unknown.            Treatment include Tylenol.  Concomitant medication was not reported.
Rash on both arms started about an hour after the vaccine, lightheadedness & dizzy, vision was a little blurry, noticed half of right side of the face was swollen around 7 pm same day of vaccination.
ON 1/28/21, REPORTED FEELING WEAK, WITH LOW GRADE FEVER AND CHILLS. STILL FELT WEAK ON 1/29 AND 1/30. EVENING OF 1/30 HE WAS FOUND IN HIS APARTMENT FEELING WEAK AND WITH SHORTNESS OF BREATH. WAS TRANSPORTED TO MEDICAL CENTER BY AMBULANCE AND ADMITTED FOR OBSERVATION.
know a person that died a week and half after receiving the first Pfizer vaccine and it was said it was from the vaccine; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated "I know a person that died a week and half after receiving the first Pfizer vaccine and it was said it was from the vaccine." The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected; Reported Cause(s) of Death: know a person that died a week and half after receiving the first Pfizer vaccine and it was said it was from the vaccine
Headache, Myalgia, Arthralgia & Fever Narrative: chills; fever; ha ; joint pain; muscle aches; swollen glands; cramps of legs
Subjective fever for 12 hours, erythematous rash anterior neck, myalgias, bilat retro orbital HA with gradual onset, Treated with Midrin and Motrin.
tingling/slight numbness on tongue and roof of inside of mouth; tingling/slight numbness on tongue and roof of inside of mouth; This is a spontaneous report from a contactable other healthcare professional (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EN6205 and expiration date was not reported), dose 1 via intramuscular route on 04Mar2021 at 10:45 (at the age of 59-year-old) as dose 1, single for COVID-19 immunisation. Medical history included allergies. Concomitant medications (other medications in two weeks) included rosuvastatin calcium (CRESTOR) and acetylsalicylic acid (BABY ASPIRIN); loratadine (CLARITIN) and fluticasone propionate (FLONASE), both taken for allergies; Airborne Imun system suppl, and Multi Vitamin Suppl. The patient previously took Shringx dose 1 on 04Feb2021 (other vaccine in four weeks) for unspecified indication. The patient did not have COVID prior vaccination and was not COVID tested post vaccination. On 04Mar2021 at 17:00, the patient experienced tingling/slight numbness on tongue and roof of inside of mouth. The clinical course of the event was reported as: tingling/slight numbness on tongue and roof of inside of mouth; symptoms started approximately 7hours after getting Pfizer COVID vaccine for 1st dose. Then gradually decreased into next day with slight symptoms still present 30hours after 1st dose. The patient did not lose taste. He inquired had anyone else reported this symptom and was this something he should be concerned about. The patient did not receive treatment for reported events. The outcome of the events was resolving.  No follow-up attempts are possible. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of an adult female subject not responding to therapy following vaccination with Hepatitis B vaccine for prophylaxis. On August 2000, May 1999 and April 1999 the subject received 3rd dose, 2nd dose and 1st dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject was tested and found to have not responded to therapy. At the time of reporting the outcome of the event was unspecified.
Approximately 1-2 days after injection, rash developed at and around injection site with noticeable itching. Approximately 2-3 days later the rash spread to upper shoulder and back area again, itching noticed and lasted about 1 wk. No treatment sought or administered.
PATIENT HAD RECEIVED 0.3ML OF UNDILUTED PEDIATRIC COVID 19 BIVALENT VACCINE (5-<12YEARS) IN ERROR. ONLY SIDE EFFECT WAS FEELING COLD LAST NIGHT. PATIENT FEELS FINE TODAY.
Have had severe chest pains starting two weeks after vaccine including bouts of sinus Tachycardia . One Tachycardia episode ended up being in the hospital with pulse at 140+ BPM for 3-6 hours. Chest pain is primarily on left side. Chest pains have been consistent for up to 5 months now.   Other symptoms include hyperacusis, burning sensation in hands, and sensitivity to light/sound.
Patient received Fluad and is only 62 years of age.  Patient was monitored and did not experience any signs/symptoms of adverse reaction.
This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Moderna 2nd Shot) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Moderna 2nd Shot). At the time of the report, WRONG PRODUCT ADMINISTERED (Moderna 2nd Shot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
Rash near the site of the shot; Swollen neck; Swollen neck that led to pain when moving; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6204), via an unspecified route of administration in the right arm on 31Mar2021 at 13:30 (at the age of 18-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to amoxicillin. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 31Mar2021, the patient experienced rash near the site of the shot, swollen neck that led to pain when moving and swallowing, chills and fever for the first night. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as the result of rash, swollen neck, neck pain, chills and fever. The clinical outcome of the events rash near the site of the shot, swollen neck, neck pain, chills and fever were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
increasing LN along  right clavicle and then among right cervical chain these past few days. about 4-5 of them with the largest on on distal right clavicle and about 1cm in size. They're all mobile.No other symptoms to speak of.  No fever, no sore throat, no redness/swelling anywhere. Some mild baseline tiredness. I had some soreness in upper arm the first few days after the vaccine , some vague right shoulder/upper back pain last weekend that I attributed to muscle strain from overuse. I noted the 2 larger 1cm lymph nodes by mid-right clavicle 4 days ago, and the 2 smaller 0.5cm right sided lower cervical chain LNs 2 days ago.
Patient developed hives with itching to left upper arm 5 minutes after receiving vaccine. Patient BP was elevated, but stable. To reduce itching and swelling, patient was given 50mg of Bendryl. Hives then spread to right arm, chest, abdomen, and then developed swelling. 9-1-1 was called. Paramedics responded and transported patient to Medical Center.
Needle came off the syringe and some of the vaccine spilled out and dripped down on her arm; Needle came off the syringe and some of the vaccine spilled out and dripped down on her arm; A spontaneous report was received from a 57-year old, female nurse, who was also a patient, who received Moderna's COVID-19 vaccine and experienced needle came off the syringe and some of the vaccine spilled out and dripped down on her arm.   The patient's medical history was not provided by the reporter. Concomitant product use was not provided by the reporter.   On 28 DEC 2020, the patient received her first of two planned doses of mRNA-1273 (Lot number: 026L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On the afternoon of 28 DEC 2020, the needle came off of the syringe and some of the vaccine spilled out and dripped down the patient's arm. She was not sure if she received the full dose. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not reported.   The events, needle came off the syringe and some of the vaccine spilled out and dripped down on her arm, were considered resolved on 28 DEC 2020.; Reporter's Comments: This case concerns a 57-year-old, female patient who received their first of two planned doses of mRNA-1273 (Lot-# 026L20A and expiration date-unknown), reporting an unexpected event of incomplete dose administered and exposure via skin contact. The events occurred the same day of vaccine administration. The reporter did not provide the causality assessment. The event of incomplete dose administered and exposure via skin contact was assessed as unlikely related to Moderna COVID-19 Vaccine.
I took my last COVID shot on March 2021 on or abt April 15 I became short of breath and was having panic attacks. I went to doctor and was treated for Aneixty.   My symptoms got worst went back to doctor and hospital er.   While in the emergency room I was diagnosed w a pulmonary embolism.   Never had this no famil issues w blood clots.  I was hospitalize for 4 days and put on blood thinners   I am still suffering from shortness of breath and panic attacks.  I also lost 22 pounds in less than a month based on not being able to eat.  This was a nightmare. I feel sure this was a side affect of the COVID shot no one cared to share the risk.  This needs to be documented and reported I?m sure there are others.
Flu shot was 5-6 wks ago and my shoulder is still very stiff and painful. ibuprofen seems to help.  If it continues, I will seek professional therapy.
VOMIT(UNABLE TO KEEP SOLID FOODS IN); DIZZINESS; DRY HEAVING(NAUSEA); JOINT PAIN; HEADACHES; This spontaneous report received from a consumer concerned a 33 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 28-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUN-2021, the subject experienced vomit (unable to keep solid foods in). On 01-JUN-2021, the subject experienced dizziness. On 01-JUN-2021, the subject experienced dry heaving (nausea). On 01-JUN-2021, the subject experienced joint pain. On 01-JUN-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headaches, dizziness, vomit(unable to keep solid foods in), dry heaving(nausea), and joint pain. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed non-serious
On Friday, 10/22/21, patient received her booster dose of Pfizer Covid-19 vaccine (LOT #: FF2587, exp: 10/30/21) at 10:30 am on her left deltoid. During assessment questions, client stated her medical history included high blood pressure and seizures with no history of allergic reactions. Client was to be a 30 minute observation. At 10:35 am, while waiting in Observation Area, client stated to Lead RN, she is feeling "dizzy" and denied experiencing this sensation during her two previous doses. Client was offered anti-gravity chair and her vitals to be taken which she denied. Client stated she just needed to "get some air" but denied any shortness of breathe and stated she "felt warm". Client was given two ice packs and a bottle of water that she drank. Client stated she did eat breakfast as well as her blood pressure and seizure medications earlier. Client was alert and oriented to person, place, time and orientation. At 10:45 pm, client stated to RN she no longer felt dizzy and denied nausea/vomiting. No further interventions needed. Client was educated by RN on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client was also encouraged to sign-up on v-safe. Client left vaccination site with a steady gait at approximately 11:00 am. VAERS completed on 10/22/21.
Face ache and headache on the right upper face and head, from just below the eye orbit to the middle of the head. Typical of where shingles would appear on the face/head.
Pt reported cold and clamy feet and hands.  Pt stated " I feel my jaws and hands g3etting tight" Vitals: 104/73, 76, 22, SPO2 100% -- > 100/59, 67, SPO2 100% -- > 120/59, 77, 20, 100% 911 Called @15:40.  Paramedics cleared pt to go home Instructed pt to go to ER if symptoms persist Pt released from the vaccination site at 16:40 in stable condition.
pain and soreness in left arm and shoulder area.  I've love movement in my left arm because of the pain.  I believe the first injection on 3/22/2021 was too deep, but that is my opinion.
Severe reaction at the site; No appetite; Fogginess in the head; Fever; Nausea; Severe headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE REACTION (Severe reaction at the site), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Fogginess in the head), PYREXIA (Fever) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE REACTION (Severe reaction at the site), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Fogginess in the head), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Severe headache). On 24-Jan-2021, INJECTION SITE REACTION (Severe reaction at the site), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. At the time of the report, DECREASED APPETITE (No appetite) had resolved, FEELING ABNORMAL (Fogginess in the head) had not resolved and HEADACHE (Severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided.
NAUSEA; FEVER 101; This spontaneous report received from a consumer concerned a 22 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination .The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced fever 101.  Laboratory data included: Body temperature (NR: not provided) 101. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea, and fever 101. This report was non-serious.
Headache, sore arm, nausea, chills, fatigue on the second day.  Completely disappeared on day 3
Inappropriate schedule of vaccine administered; severe shoulder pain; hard time lifting his arm; This spontaneous report was received from a pharmacist concerning a male patient of unknown age. No information about his current condition, medical history or concomitant therapy was reported.   On 09-OCT-2020, the patient was vaccinated with first dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, route and lot# were not reported) as prophylaxis. On 08-NOV-2021, he was administered the second dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (at the dose of 0.5 ml, route was not reported; lot#T032761, expiry date 30-MAY-2022) again as prophylaxis (inappropriate schedule of product administration).   After the second time of injection, in November 2021, the patient was complaining of sever should pain and having a hard time lifting his arm. No treatment was given for the events. At the time of reporting, all the events were not resolved. Action taken with suspect vaccine was not applicable.   The causality between the events and suspect vaccine was not reported.
Patient was hospitalized for COVID treatment.  5/19/21 - 5/20/21
This spontaneous report was received from the Vaccine Coordinator referring to a 15 month year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 28-SEP-2017, the patient was vaccinated with an improperly stored dose of VARIVAX with one of these lot #'s reported M017292, expiration date on 07-APR-2018; lot # N017701, expiration date on 09-JUN-2019 or with lot # N019127, expiration date on 22-JUN-2019 (Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 7.52 F degrees Fahrenheit for 24 hour, and had a previous temperature excursion of 5.5 F degrees Fahrenheit for 1 hour. There was a digital data logger involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA008693.
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 51 year-old male patient. On 29-Sep-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported on 12-Jun-2016) 0.5mL via the intramuscular route. The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34d degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
At the area of injection ( my left arm) it became red, hot & itching, also my throat is scratchy.  I have been applying Benadryl cream & taking Benadryl  Reported it to pharmacy where I got the Vaccination
Large painful Boil like eruptions on the lips of vagina.  Treated with zinc oxide
began running a fever that was 103 shortly p/recvd DTP#3; was given APAP; seen by MD 4MAR92 who recommended not to give pertussis again;